Sucralfate (sucralfate oral) NDC 68094-041

NDC codes

FDA NDC Directory

Product NDC (as listed)68094-041Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68094-0041Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68094-041-61	68094004161	10 TRAY in 1 CASE (68094-041-61) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (68094-041-59)Marketed from Jan 30, 2025
68094-041-62	68094004162	3 TRAY in 1 CASE (68094-041-62) / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE (68094-041-59)Marketed from Jan 30, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sucralfate
Generic name (nonproprietary): sucralfate oral
Active ingredients: Sucralfate — 1 g/10mL
Dosage form: Suspension
Route: Oral
Labeler: Precision Dose, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209356
Marketing start: Jan 30, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Organometallic Compounds (Chemical structure)
Identifiers: Product ID 68094-041_f2fb0919-1f13-4ca2-bf04-254c1e44b86cSPL ID f2fb0919-1f13-4ca2-bf04-254c1e44b86cSPL set ID 0dc592e9-541c-4fac-8ab5-829d43521c01RxCUI 313123UNII XX73205DH5
Pharmacologic class: Aluminum Complex

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468094004161 followed by a unit qualifier and the quantity

Package 68094-0041-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 28, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Sucralfate Oral Suspension is indicated in the short-term (up to 8 weeks) treatment of active duodenal ulcer.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 209356

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209356
Product	Strength	Form · route	Labeler	Product NDC
Sucralfatesucralfate oral	Sucralfate 1 g/10mL	SuspensionOral	Cardinal Health 107, LLC	55154-4348
Sucralfatesucralfate oral	Sucralfate 1 g/10mL	SuspensionOral	AvPAK	50268-745
Sucralfatesucralfate oral	Sucralfate 1 g/10mL	SuspensionOral	Amneal Pharmaceuticals LLC	65162-062
Sucralfatesucralfate oral	Sucralfate 1 g/10mL	SuspensionOral	AvKARE	42291-781